Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 May;44(5):431–432. doi: 10.1136/jcp.44.5.431

Red cell aplasia in myelodysplastic syndrome.

P J Williamson 1, D G Oscier 1, A J Bell 1, T J Hamblin 1
PMCID: PMC496880  PMID: 1904455

Abstract

Six cases of red cell aplasia occurring in patients with myelodysplastic syndromes (MDS) showed a diversity of clinical course and prognosis. In some patients red cell aplasia may have represented an evolution of MDS while in others autoimmune destruction of erythoblasts may have been the mechanism. A proliferative phase is seen in many of these patients, the clinical importance of which is uncertain.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammus S. S., Yunis A. A. Acquired pure red cell aplasia. Am J Hematol. 1987 Mar;24(3):311–326. doi: 10.1002/ajh.2830240312. [DOI] [PubMed] [Google Scholar]
  2. Bolton-Maggs P. H., Galloway M. J., Rhodes E. G. Pure red cell aplasia heralding chronic myelomonocytic leukaemia. Clin Lab Haematol. 1989;11(1):61–65. doi: 10.1111/j.1365-2257.1989.tb00176.x. [DOI] [PubMed] [Google Scholar]
  3. Cook M. K. Red cell hypoplasia associated with myeloproliferative and myelodysplastic syndrome. J Clin Pathol. 1989 Aug;42(8):890–891. doi: 10.1136/jcp.42.8.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Craig A., Geary C. G., Love E. M., Liu-Yin J. Red cell hypoplasia, thrombocytosis, and leucocytosis: myelodysplastic and proliferative syndrome. J Clin Pathol. 1988 Nov;41(11):1168–1170. doi: 10.1136/jcp.41.11.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dessypris E. N., McKee C. L., Jr, Metzantonakis C., Teliacos M., Krantz S. B. Red cell aplasia and chronic granulocytic leukaemia. Br J Haematol. 1981 Jun;48(2):217–225. doi: 10.1111/j.1365-2141.1981.tb08455.x. [DOI] [PubMed] [Google Scholar]
  6. Kerkhofs H., Hagemeijer A., Leeksma C. H., Abels J., den Ottolander G. J., Somers R., Gerrits W. B., Langenhuiÿen M. M., von dem Borne A. E., Van Hemel J. O. The 5a-chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands. Br J Haematol. 1982 Nov;52(3):365–381. doi: 10.1111/j.1365-2141.1982.tb03906.x. [DOI] [PubMed] [Google Scholar]
  7. López-Guillermo A., Cervantes F., Sacanella E., Florensa L., Rozman C. Pure red cell aplasia associated with chronic myelomonocytic leukaemia. Clin Lab Haematol. 1989;11(4):410–411. doi: 10.1111/j.1365-2257.1989.tb00243.x. [DOI] [PubMed] [Google Scholar]
  8. Mufti G. J., Figes A., Hamblin T. J., Oscier D. G., Copplestone J. A. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol. 1986 May;63(1):143–147. doi: 10.1111/j.1365-2141.1986.tb07504.x. [DOI] [PubMed] [Google Scholar]
  9. Oscier D. G., Worsley A., Darlow S., Figes A., Williams J. D., Hamblin T. J. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score. Leuk Res. 1989;13(9):833–839. doi: 10.1016/0145-2126(89)90097-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES